ONCODESIGN
Pharmacological expertise for anticancer therapies from target to patient : a unique oncology preclinical CRO. Founded in 1995, Oncodesign is a biopharmaceutical company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform. Technological innovation lies at the heart of Oncodesign’s model—the Etiology, Discovery and Experimentation activities designed and implemented by Oncodesign contribute to a more effective approach to the phenome... non of innate and acquired resistance, more effective treatments and a reduction in therapeutic failures. Working alongside big pharma, biotech’s, public research institutions and investment groups, Oncodesign orients the research and development of new therapeutic and diagnostic tools. Through its range of services, partnerships and licensing programs, Oncodesign’s offering can meet the full range of innovation needs. Oncodesign is listed on the Euronext Growth Paris market and possesses a stable ownership structure with a majority owner committed to its development.
ONCODESIGN
Industry:
Biotechnology Health Care Therapeutics
Founded:
1995-01-01
Address:
Dijon, Bourgogne, France
Country:
France
Website Url:
http://www.oncodesign.com
Total Employee:
101+
Status:
Active
Contact:
+33 (0)3.80.78.82.60
Email Addresses:
[email protected]
Total Funding:
29.41 M USD
Technology used in webpage:
Mobile Non Scaleable Content ASP.NET 3 To 9 CcTLD Redirects Orange
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
OncoGenex
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
OncoTherapy Science
OncoTherapy Science deliver cancer therapeutics and treatments to patients suffering from cancer.
Progenteq
Progenteq develops cartilage repair therapy to regenerate damaged cartilage.
WntResearch
WntResearch develops anti-metastatic therapies for the treatment of cancer patients.
Current Employees Featured
Founder
Stock Details
Investors List
Oséo
Oséo investment in Venture Round - Oncodesign
Banque de Vizille
Banque de Vizille investment in Series C - Oncodesign
Avenir Entreprises Gestion
Avenir Entreprises Gestion investment in Series C - Oncodesign
Official Site Inspections
http://www.oncodesign.com Semrush global rank: 4.45 M Semrush visits lastest month: 2.46 K
- Host name: od-5e32b6.ch2.infomaniak.ch
- IP address: 195.15.224.139
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Oncodesign"
Management - Oncodesign Precision Medicine
Management guarantees an efficient organization. Executive Management. ... In 1995, he founded Oncodesign Biotechnology in Dijon. From that point, he has earned a reputation as a serial entrepreneur in life sciences. He is the root to …See details»
Oncodesign Precision Medicine
Oncodesign Precision Medicine. To find the best therapeutic path. OPM’s mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis …See details»
Oncodesign Services - CRO in Drug discovery
Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs. …See details»
Management - Oncodesign Services
More than 20 years of managing experience in scale-up and high growth environments, Gilles joined Oncodesign Services in 2022 as Chief Financial Officer. He takes the head of the …See details»
Oncodesign Services - LinkedIn
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the ...See details»
Oncodesign Services - Crunchbase Company Profile
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. From target identification to IND filing, the company contributes to the development of innovative therapies in oncology, …See details»
Oncodesign - VentureRadar
Oncodesign is a biopharmaceutical company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform. Technological innovation lies at the …See details»
Oncodesign Company Profile - Craft
Dec 21, 2022 Oncodesign is an international leader in the preclinical evaluation of anticancer therapies and stands out in the industry on the following points : Innovation: Oncodesign …See details»
Management - Oncodesign Precision Medicine
Management guarantees an efficient organization. Executive management. ... In 1995, he founded Oncodesign Biotechnology in Dijon. From that point, he has earned a reputation as a serial entrepreneur in life sciences. He is the root to …See details»
About us - Oncodesign Precision Medicine
On 1 July 2022, Oncodesign announced the spin-off and transfer of its Biotech activity including AI to Oncodesign Precision Medicine (OPM). With its diversified portfolio of technologies, molecules, and therapeutic targets, OPM has well …See details»
Oncodesign Services - LinkedIn
Oncodesign Services | 12,215 followers on LinkedIn. A leading CRO in drug discovery and preclinical services | Oncodesign Services is a Contract research organization (CRO) …See details»
Oncodesign Confirms Its Very Good Results in 2021 and an …
Apr 7, 2022 Philippe GENNE, Chairman and CEO of Oncodesign, states: “Oncodesign has achieved several major targets, two years after implementing its new organization into …See details»
Oncodesign Services - Scientist.com
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the …See details»
Company profile | Oncodesign Services | My Biologics Partner
Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and …See details»
New organization of independent Business Units - oncodesign.com
Oncodesign reviewed its organization structure into independent Business Units owing to the growth in the Service business and the emergence of a more mature product portfolio, …See details»
Brand history, mission, vision | Oncodesign - Vector of innovation
Our mission. Founded in 1995, Oncodesign’s mission is to discover effective therapies for the benefit of patients suffering from cancer or pathologies without therapeutic solutions.In …See details»
Strategic Organization Design for CHROs | Enhance Agility and
Mar 6, 2025 Effective organization design requires more than just aligning with business strategy; it demands a deep understanding of how work happens within the organization. …See details»
Resources | Oncodesign Services
Oncodesign Services and ZoBio will be attending to Bio US 2024 ! Fix a meeting now . Read more . Scientific publication. 13/05/2024 How Oncodesign Services contributed to the …See details»
Our history - Oncodesign Precision Medicine
Oncodesign acquired the Ulis Research Center, with more than 50 highly qualified employees working in drug discovery, specifically in medicinal chemistry, biology, in vivo pharmacology …See details»
Oncodesign Precision Medicine
Oncodesign Precision Medicine. identifier la voie thérapeutique efficace. La mission d’OPM est d’apporter aux patients des solutions thérapeutiques et diagnostiques efficaces pour traiter les …See details»